The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers
Objective: To quantify the impact of varying severity levels on caregivers’ burden and health-related quality of life (HRQoL). Background: PSP is a progressive disease. Patients…The Effectiveness of Rehabilitation Using Honda Walking Assist in Parkinson’s Disease Patients; The Gait Analysis by a Markerless Motion Capture System
Objective: We verified the usefulness of an automatic gait and posture analyzer for estimation of rehabilitation using Honda Walking Assist (HWA). Background: The abnormal posture…Immediate effect of the virtual and augmented reality and neurofunctional physiotherapy on postural control and cognition in patients with Parkinson’s disease: a randomized clinical trial
Objective: To evaluate the immediate effect of augmented reality (AR), virtual reality (VR) and neurofunctional physiotherapy (NP) in postural control and cognition of patients with…Factors Influencing Decision-Making About End of Life Care in Patients With Parkinson’s Disease and Their Family Members
Objective: The aim of the research was to determine factors influencing decision-making about end of life care in patients with Parkinson´s disease (PD) and their…Differential Gait Progression in idiopathic Parkinson’s disease with and without freezing of gait
Objective: To develop a predictive algorithm for freezing of gait (FOG) in Parkinson’s disease (PD) through longitudinal objective gait assessment. Background: The presence of FOG…Pilot testing of the Integrated Parkinson’s Disease Care Network: feasibility, efficacy outcomes and cost description analysis
Objective: To evaluate a new model of care delivery in PD, the Integrated Parkinson’s disease Care Network (IPCN), in terms of implementation, health-related outcomes, patient/care…Inhibition of mitochondrial complexes induces unique transcriptomic and epigenetic profiles: implications to neurodegeneration induced movement disorders
Objective: To compare the neurotoxicological hallmarks induced by inhibitors of mitochondrial complex I (CI- 1- methyl-4- phenylpyridinium; MPP+), complex II (CII- 3- nitropropionic acid; 3-…Population Exposure-Response Models of Apomorphine Sublingual Film in Healthy Subjects and Patients With Parkinson’s Disease and “OFF” Episodes
Objective: Exposure-response models were developed to characterize the relationship between apomorphine exposure and (1) efficacy using Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease…A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment
Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…Neuroprotective effect of Yerba mate (Ilex paraguariensis) in a Drosophila model of Parkinson ’s disease
Objective: To test the neuroprotective capacity of Yerba Mate (YM) in an in vivo model of Parkinson's disease. Background: Parkinson's disease (PD) is caused by the…
- « Previous Page
- 1
- …
- 143
- 144
- 145
- 146
- 147
- …
- 217
- Next Page »